Claris Lifesciences shares are on watch after PE investor Carlyle exited.
Carlyle sold 11.29 per cent in the company in a block deal on Monday at Rs 277 a share, according to BSE data.
The data showed that among other investors, Emsaf Mauritius and Tata AIA Life Insurance Company bought in block deals.
At 10.35 am, the stock was trading up 1.31 per cent or Rs 3.60 at Rs 278. The stock had lost 11.2 per cent on Monday.
The PE investor exited after nine years and two-fold returns, analysts said.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.